Scotland will lead the way in a £26 million drugs trial. The SCOT Trial, (Standard Care versus Celecoxib Outcome Trial), will compare different types of treatment for arthritis, a series of conditions which affects around nine million people in the UK.
Click Here to read the entire article...
